The Director II, Oncology Market Access Marketing, Hematology provides strategic leadership for market access across AbbVie's current and future U.S. Hematology portfolio. This individual establishes the portfolio access vision and leads payer and channel strategy, pricing and contracting, launch readiness, financial planning, customer engagement, market shaping, and team development.

The Director II serves as the senior Hematology Market Access partner to Oncology leadership and represents the Market Access perspective in brand, portfolio, pipeline, and executive decision-making forums. This leader translates clinical, economic, payer, policy, reimbursement, competitive, and customer dynamics into clear portfolio priorities and executable access strategies.

The Director II leads collaboration across Brand Marketing, Market Access field organizations, Finance, Medical Affairs, Health Economics and Outcomes Research, Market Access Insights, Trade, Legal, Regulatory, Patient Services, Policy, Government Affairs, and external alliance or co-commercialization partners. This role requires strong business ownership, financial acumen, people leadership, executive influence, and the ability to guide teams through complex and evolving access environments.

Key Responsibilities

Hematology Portfolio Strategy

• Establish and lead the overarching U.S. market access strategy for the current and future Hematology portfolio.
• Set strategic priorities across products, indications, pipeline assets, channels, customer segments, and lifecycle stages.
• Lead access strategy across commercial payers, pharmacy benefit managers, Medicare, Medicaid, Federal, integrated delivery networks, health systems, group purchasing organizations, and community oncology channels.
• Translate clinical, economic, policy, reimbursement, customer, and competitive insights into portfolio strategies and channel-specific action plans.
• Develop and communicate the Hematology Market Access point of view on emerging market developments, policy changes, competitive entrants, access risks, and opportunities.
• Apply a One AbbVie perspective when assessing portfolio tradeoffs, investments, financial impact, and enterprise risk.
• Represent Hematology Market Access in Oncology leadership, portfolio, pipeline, and long-range planning discussions.

Launch and Lifecycle Leadership

• Lead Market Access readiness and execution for new Hematology products, indication expansions, and lifecycle initiatives.
• Establish launch access objectives, pricing and contracting posture, evidence needs, customer-engagement priorities, field readiness requirements, access measures, and escalation processes.
• Ensure access considerations are incorporated into brand planning, Integrated Brand Teams, launch-readiness reviews, annual planning, long-range planning, and executive governance.
• Guide access planning for oral oncology, medical-benefit, buy-and-bill, specialty, and rare-disease products, as applicable to the portfolio.
• Monitor coverage, medical and pharmacy policies, utilization management, reimbursement, account activation, channel performance, and emerging access barriers.
• Lead cross-functional resolution of significant payer, channel, reimbursement, policy, or operational access issues.
• Incorporate customer and field insights into launch planning and post-launch strategy refinement.

Pricing, Contracting, and Financial Planning

• Lead the development and evolution of payer, PBM, GPO, Federal, and community oncology contracting strategies across the Hematology portfolio.
• Guide traditional rebate, value-based agreement, innovative contracting, and GPO contracting approaches based on current and anticipated market conditions.
• Lead the Market Access contribution to annual Plan, latest best estimate, long-range planning, forecasting, and resource-allocation processes.
• Assess the access, financial, and government-pricing implications of major strategic and contracting decisions.
• Partner with Finance, Pricing, Contracting, Trade, Legal, Policy, and Market Access leadership to frame options, risks, sensitivities, and recommendations.
• Ensure contracting and financial assumptions reflect customer insights, field intelligence, account performance, policy developments, and competitive dynamics.
• Establish effective governance, performance measures, and escalation pathways for major contracting and access investments.

Customer and Field Strategy

• Develop differentiated clinical and economic value strategies for payer, PBM, GPO, Federal, institutional, IDN, and community oncology customers.
• Partner with Market Access account teams and Oncology field leadership to translate portfolio priorities into actionable customer-engagement strategies.
• Establish structured feedback mechanisms that integrate customer insights, field observations, access trends, policy changes, and competitive intelligence into strategy evolution.
• Ensure field teams have the training, evidence, resources, and escalation support required for effective customer engagement and access execution.
• Promote meaningful customer exposure for Hematology Market Access team members through field engagements, advisory activities, and relevant professional organizations.
• Communicate portfolio strategy, marketplace developments, performance, risks, and required actions to field and leadership audiences.

Enterprise and Alliance Leadership

• Serve as the senior Hematology Market Access partner to Oncology commercial, brand, functional, and U.S. Market Access leadership.
• Represent Market Access in Integrated Brand Teams, pipeline teams, strategic planning forums, and executive decision-making processes.
• Align Brand, Market Access, Field, Finance, Medical, HEOR, Trade, Legal, Regulatory, Patient Services, Policy, and Government Affairs stakeholders around shared access priorities.
• Establish clear governance, ownership, decision rights, milestones, performance measures, and escalation pathways for priority workstreams.
• Provide concise recommendations that clarify strategic choices, access implications, financial impact, risks, and required decisions.
• Lead Market Access collaboration with external alliance and co-commercialization partners, where applicable.
• Connect Hematology priorities with broader Oncology and U.S. Market Access strategies, capabilities, and operating standards.
• Maintain an effective operating cadence for portfolio strategy, access performance, launch readiness, marketplace developments, and executive communication.

People and Organizational Leadership

• Lead, coach, and develop a high-performing Hematology Market Access Marketing team.
• Establish a clear team mission, portfolio priorities, roles, decision rights, expectations, and ways of working.
• Build an inclusive, transparent, high-trust, and high-accountability culture.
• Empower team members to operate with a business-owner mindset and confidently represent Market Access with brand, field, and functional leaders.
• Develop talent through coaching, timely feedback, recognition, stretch assignments, and cross-functional exposure.
• Build individual development and succession plans aligned with future Oncology Market Access needs.
• Assess and evolve the team structure, capabilities, and allocation of responsibilities as the Hematology portfolio changes.
• Promote continuous learning across access strategy, customer dynamics, pricing, contracting, financial planning, policy, and enterprise leadership.

Performance and Operational Excellence

• Establish clear measures for portfolio access, launch readiness, contracting execution, customer engagement, financial performance, and organizational effectiveness.
• Create consistent portfolio reporting and executive communication regarding strategy, progress, risks, opportunities, and decisions.
• Monitor execution against priorities, milestones, resource commitments, contracting plans, and financial assumptions.
• Identify and escalate material access issues early and drive clear ownership of resolution.
• Prioritize resources across brands and workstreams, simplifying or discontinuing lower-value activities when appropriate.
• Maintain operating processes that support compliant, efficient, and high-quality execution